✦ LIBER ✦

Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor therapy in rheumatoid arthritis

✍ Scribed by Cañete, J. D. (author);Celis, R. (author);Moll, C. (author);Izquierdo, E. (author);Marsal, S. (author);Sanmartí, R. (author);Palacín, A. (author);Lora, D. (author);De La Cruz, J. (author);Pablos, J. L. (author)

Book ID: 120218486
Publisher: BMJ Publishing Group
Year: 2008
Tongue: English
Weight: 224 KB
Volume: 68
Category: Article
ISSN: 0003-4967
DOI: 10.1136/ard.2008.089284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synovial fibroblast hyperplasia in rheum

Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathologic correlations and partial reversal by anti–tumor necrosis factor therapy

✍ Elena Izquierdo; Juan D. Cañete; Raquel Celis; Manuel J. Del Rey; Alicia Usategu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 743 KB

Immunogenicity of anti-tumour necrosis f

Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis

✍ Jung, Seung Min; Kim, Hyun-Sook; Kim, Hae-Rim; Kim, Na Young; Lee, Jung-Hwa; Kim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Long-term anti-tumour necrosis factor th

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima–media thickness in female patients with active rheumatoid arthritis

✍ A. Ferrante; A. R. Giardina; F. Ciccia; G. Parrinello; G. Licata; G. Avellone; E 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB

TUMOUR NECROSIS FACTOR α (TNF-α) INTERFE

TUMOUR NECROSIS FACTOR α (TNF-α) INTERFERES WITH Fas-MEDIATED APOPTOTIC CELL DEATH ON RHEUMATOID ARTHRITIS (RA) SYNOVIAL CELLS: A POSSIBLE MECHANISM OF RHEUMATOID SYNOVIAL HYPERPLASIA AND A CLINICAL BENEFIT OF ANTI-TNF-α THERAPY FOR RA

✍ Shiro Ohshima; Toru Mima; Mitsuko Sasai; Katsuhiro Nishioka; Masatoshi Shimizu; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 868 KB

Anti-tumour necrosis factor therapy in r

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

✍ Askling, J. (author);Baecklund, E. (author);Granath, F. (author);Geborek, P. (au 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 147 KB

Anti-tumour necrosis factor therapy in r

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

✍ Askling, J. (author);Baecklund, E. (author);Granath, F. (author);Geborek, P. (au 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 147 KB